111 Capital’s CVS Health CVS Stock Holding History

111 Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,215	Closed	-$231K	–	519
2026 Q1	$231K	Sell	3,215 -3,350	-51%	-$258K	0.06%	289
2025 Q4	$521K	Sell	6,565 -8,387	-56%	-$661K	0.11%	155
2025 Q3	$1.13M	Buy	+14,952	New	+$1.02M	0.21%	101
2025 Q1	–	Sell	-17,597	Closed	-$790K	–	483
2024 Q4	$790K	Buy	+17,597	New	+$987K	0.17%	125

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

111 Capital's CVS Position: Q2 2026 in Review

111 Capital sold out of CVS Health (CVS) in Q2 2026, closing a stake of 3,215 shares — an estimated $231K sold.

111 Capital first reported a position in CVS in Q4 2024 and held it in 4 quarters. The position peaked at $1.13M in Q3 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

111 Capital reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
111 Capital sold 3,215 CVS Health shares in Q2 2026, an estimated $231K.
111 Capital first reported a position in CVS Health in Q4 2024 and held it in 4 quarters.
111 Capital's CVS Health position peaked at $1.13M in Q3 2025.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.